Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer

To evaluate the effectiveness and safety of camrelizumab combined with radiotherapy and chemotherapy for recurrent or metastatic cervical cancer

  • 0 views
  • 20 May, 2021
  • 1 location
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (innovaTV 301)

This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cervical cancer that has spread to other parts of the body (metastatic) or has come back after being treated (recurrent). Participants in this trial will be …

immunomodulator
pemetrexed
adenocarcinoma
gemcitabine
topotecan
  • 3 views
  • 19 Sep, 2023
  • 11 locations
A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

, Recurrent, or Metastatic Cervical Cancer.

adenocarcinoma
carcinoma
carboplatin
measurable disease
metastatic cervical cancer
  • 0 views
  • 24 Apr, 2022
  • 1 location
Ultrafractionated Radiation Therapy for Metastatic Cervical Cancer

To improve overall survival in patients with metastatic cervical cancer by loco-regional therapy with ultra-fractionated radiation therapy

metastasis
metastatic cervical cancer
hysterectomy
cancer
measurable disease
  • 0 views
  • 16 Sep, 2023
  • 1 location
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer

This study is an open, single-arm, multicenter phase II study to investigate the efficacy and safety of SG001 for relapsed or metastatic uterine cervical cancer patients with PD-L1 positive

immunomodulator
adenosquamous carcinoma
adenocarcinoma
carcinoma
measurable disease
  • 0 views
  • 30 Nov, 2021
  • 1 location
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

, Recurrent, or Metastatic Cervical Cancer

chemoradiotherapy
adenocarcinoma
carcinoma
carboplatin
metastatic cervical cancer
  • 0 views
  • 10 May, 2022
  • 5 locations
Phase II Study of Stereotactic Body Radiation Therapy and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

in patients with recurrent, persistent, or metastatic cervical cancer.

MRI
adenocarcinoma
cancer
metastatic cervical cancer
squamous cell carcinoma
  • 38 views
  • 11 Oct, 2022
  • 2 locations
A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Efficacy and safety of Tislelizumab combined with Bevacizumab and chemotherapy in patients with persistent, recurrent or metastatic cervical cancer.

adenosquamous carcinoma
growth factor
adenocarcinoma
carcinoma
carboplatin
  • 0 views
  • 04 Oct, 2022
  • 1 location
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

This is a phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer that had failed first line of therapy. The

growth factor
pembrolizumab
measurable disease
metastatic cervical cancer
aptt
  • 0 views
  • 20 Aug, 2023
  • 2 locations
Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer (TIL)

A study that aimed to assess the safety and anti-tumor activity of C-TIL052A cell therapy in subjects with persistent, recurrent and/or metastatic cervical cancer.

metastatic cervical cancer
  • 0 views
  • 04 Oct, 2022
  • 2 locations